Villeurbanne, France

Alain Vaganay

This inventor holds 1 USPTO granted patent. Top assignee: Rhone Merieux. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alain Vaganay. Retrieved from https://idiyas.com/inventor/alain-vaganay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Alain Vaganay

Introduction

Alain Vaganay is a notable inventor based in Villeurbanne, France. He has made significant contributions to the field of vaccine development, particularly in relation to viral antigens. His work is recognized for its potential impact on public health.

Latest Patents

Alain Vaganay holds a patent for the "Preparation of antigens of and of vaccines for the virus of mystery." This patent showcases his innovative approach to vaccine formulation and highlights his commitment to advancing medical science. He has 1 patent to his name.

Career Highlights

Vaganay is associated with the company Rhône Merieux, where he applies his expertise in immunology and vaccine research. His role at Rhône Merieux has allowed him to work on groundbreaking projects that aim to improve vaccine efficacy and safety.

Collaborations

Throughout his career, Alain has collaborated with esteemed colleagues such as Andre Brun and Marie-Claude Tardy. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alain Vaganay's contributions to vaccine development and his innovative spirit make him a significant figure in the field of immunology. His work continues to inspire future advancements in medical research and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…